Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NRP1 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | UBE3D | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | TMEM183A | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | ACTN4 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | FMN1 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | KARS | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | NELL2 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | HNRNPL | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | SUZ12 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | NUP58 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |